Feedback / Questions
MDCO-216 - Novartis
BioCentury newsmakers in the biotech industry
(The Medicines Company)
-
Sep 7, 2012 -
Anticipated NDA filing for dyslipidemia beyond 2016
Anticipated NDA
•
Dyslipidemia
http://www.larvolonline.com/tlg/ccdb/TheMedicinesCompanyBioCenturyNewsMakersInTheBiotechIndustrySep072012.pdf
Sep 7, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR 7)